Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
At the beginning of Glioblastoma (GBM) Consciousness Week, Mind Tumour Analysis is saying a brand new collaboration with Beatson Most cancers Charity to...
A significant Scandinavian examine by Karolinska Institutet reveals that GLP-1 analogs, utilized in diabetes and weight problems remedy, don't improve thyroid most cancers...
